GEL-one 30 MG/3 ML syringe 3ML
Ended Awarded
- Contract number
- SPE2DB26FX4DA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,245
Award facts
- Contract value 100% obligated
- $18,245.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,245 delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on October 31, 2025, with completion scheduled for November 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Gel-One is a hyaluronic acid-based injectable treatment used primarily for knee osteoarthritis, representing a specialized pharmaceutical commodity within the company's broader medical supply portfolio.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement across military and veteran healthcare systems, supplying an extensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's demonstrated capability to fulfill federal medical supply requirements through competitive procurement positions it as a key provider within the DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB26FX4DA?
SPE2DB26FX4DA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FX4DA worth?
The government has obligated $18,245 on SPE2DB26FX4DA.
Is contract SPE2DB26FX4DA an order under another contract?
Yes. SPE2DB26FX4DA is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4DA competed?
The extent of competition for SPE2DB26FX4DA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award